Axiom Therapeutics Private Limited
About Axiom Therapeutics Private Limited
Data last updated:
Axiom Therapeutics Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33100TN2011PTC081746. Its GSTIN is 33AAJCA6969N1ZZ (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Venkata Narasimhan and Sengutuvan Venkataachalam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.4 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹20.67 Lakh (net margin 4.7%) and EBITDA of ₹31 Lakh (EBITDA margin 7%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 2% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹25 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Axiom Therapeutics Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressWing A Mezzanine Floor Sp – 30 Developed Plot SIDCO Industrial, Estate, Chennai, Tamil Nadu, India – 600032
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Axiom Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Axiom Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Axiom Therapeutics Private Limited, buy the company report.
Financials of Axiom Therapeutics Private Limited
FY 2025 filings availableAxiom Therapeutics Private Limited reported revenue of ₹4.4 Cr (up 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 6% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7% | ||||
| Net Profit Margin | 4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Axiom Therapeutics Private Limited, buy the company report.
Board of directors of Axiom Therapeutics Private Limited
Axiom Therapeutics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Narasimhan Also directs: Ramachandra Healthcare Private Limited | Director | 02 Aug 2011 | 15 Years 3 Months | Current |
| Sengutuvan Venkataachalam | Director | 05 Sep 2016 | 10 Years 2 Months | Current |
Auditor
Axiom Therapeutics Private Limited is audited by T.Selvaraj and Co for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T.Selvaraj and Co | FY 2017 | 003703S |
Shareholding
The shareholding of Axiom Therapeutics Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Axiom Therapeutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Aug 2012 | 10377687 | City Union Bank Lttd | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Axiom Therapeutics Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Laboratoires Griffon Pvt. Ltd. and Anr. | Disposed |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Laboratoires Griffon Pvt. Ltd. and Anr. and 1 other | Disposed |
To see the full case history of Axiom Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Axiom Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Axiom Therapeutics Private Limited has a workforce of 4 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 4 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Axiom Therapeutics Private Limited, buy the company report.
GST
Axiom Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAJCA6969N1ZZ | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Axiom Therapeutics Private Limited, buy the company report.
Recent activity
Axiom Therapeutics Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Subramanian Sivaraman ceased to be Director on 05 Mar 2019.
Frequently asked questions
Axiom Therapeutics is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 August 2011 (15+ years old) and is registered under CIN U33100TN2011PTC081746.
Axiom Therapeutics has 2 current directors:
- Venkata Narasimhan - Director
- Sengutuvan Venkataachalam - Director
The latest financial statements of Axiom Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Axiom Therapeutics is 33AAJCA6969N1ZZ, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Axiom Therapeutics is U33100TN2011PTC081746. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axiom Therapeutics has 2 court cases on record: 2 filed against it.
Axiom Therapeutics was incorporated on 02 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chennai.
Subramanian Sivaraman ceased to be Director on 05 Mar 2019. Sengutuvan Venkataachalam was appointed as Director on 05 Sep 2016. Venkata Narasimhan was appointed as Director on 02 Aug 2011.
The registered office of Axiom Therapeutics is at Wing A Mezzanine Floor Sp – 30 Developed Plot SIDCO Industrial, Estate, Chennai, Tamil Nadu, India – 600032.
Axiom Therapeutics operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
